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Cholesterol metabolism is not well understood in the retina,
where CYP27A1 and CYP46A1 are the major cholesterol-
metabolizing enzymes. Using Cyp27a1/Cyp46a1/ mice,
Saadane et al (Am J Pathol 2014, 184:2403e2419) studied
the signiﬁcance of cholesterol metabolism in retina. Despite
normal serum cholesterol and glucose levels, Cyp27a1/
Cyp46a1/mice had changes in the retinal vasculature, retina,
and several nonocular organs, and they exhibited retinal
macrophage activation and oxidative stress in the photoreceptor
inner segments, mimicking other retinal diseases. The affected
organs developed pathology that reﬂected tissue response to
cholesterol overloadand impairedoxysterol production.Retinal
cholesterolmetabolismappears to be important formaintenance
of the normal retina, suggesting a novel model for pharmaco-
logical evaluation of molecules for treatment of diseases
affecting retinal vasculature.
INPP4B Polymorphisms Linked to MS
Nerve conduction impairment commonly occurs in multiple
sclerosis (MS), andmeasurementofevokedpotentials arewidely
used for diagnosis and prognosis. Lemcke et al (Am J Pathol
2014, 184:2420e2429) used a classical genetic approach to
identify novel genes controlling nerve conduction in mice.
Quantitative trait mapping identiﬁedEAE31, a locus controlling
latency of motor-evoked potentials and clinical onset of experi-
mental autoimmune encephalomyelitis (EAE). Detailed ﬁne
mapping identiﬁed inositol polyphosphate-4-phosphatase, type
II (Inpp4b) as the quantitative trait gene for EAE31. Transgenic
mice of different strains carrying speciﬁc polymorphisms under
the control of a ubiquitous neuronal promoter validated Inpp4b
involvement. Interestingly, an association of INPP4B poly-
morphisms is also conserved in humans andwas associatedwith
MS incidence in German and Spanish cohorts. INPP4B poly-
morphisms are candidate prognostic markers for MS.
KDM5C Is Associated with Poor Prognosis in
Prostate Cancer
Studies have implicated histone lysine demethylases (KDMs) in
prostate cancer; however, the speciﬁc role of KDM5C remains
unexplored. Stein et al (Am J Pathol 2014, 184:2430e2437)
systematically studied the expression pattern and the biolog-
ical relevance of KDM5C in two independent radical prosta-
tectomy cohorts. Positive nuclearKDM5Cstaining signiﬁcantlyCopyright ª 2014 American Society for Investigative Pathology.
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survival. Nuclear KDM5C expression was conﬁrmed as an in-
dependent prognostic parameter. Strikingly, the prognostic
value of nuclear KDM5C expression for progression-free sur-
vivalwas exclusively pronounced forGleason group 7.KDM5C
knockdown retarded prostate cancer cell growth in vitro and
induced regulation of several proliferation-associated genes.
KDM5C thus represents a potential novel drug target in prostate
cancer.
FOXO1 Accelerates Skin Wound Healing
The full involvement and mechanism of action of the forkhead
box O (FOXO) family of transcription factors in tissue-repair
processes remains largely unknown. Mori et al (Am J Pathol
2014, 184:2465e2479) studied the molecular functions of
FOXO family gene members in skin wound healing and their
potential application in a clinical setting. Foxo1 and Foxo3a
were both up-regulated during murine skin wound healing.
Foxo1þ/ mice exhibited accelerated skin wound healing,
enhanced keratinocyte migration, reduced inﬂammatory
response, and decreased scarring; no wound phenotype was
observed in Foxo3a/ mice. Acute knockdown of the Foxo1
protein at wound sites improved the quality of healing. Simi-
larly, altered FOXO1 expression in human patients was asso-
ciated with the development of keloids (growing scars), in a
race-dependent manner. Molecular targeting of FOXO1 may
improve the quality of healing and reduce pathological scarring.
SDC4 Regulates MMP-3 Expression in Disc
Degeneration
The relationship between matrix metalloproteinase-3 (MMP-3)
expression and syndecan 4 (SDC4) in intervertebral disc
degeneration (IVDD) remains poorly deﬁned. Wang et al (Am
J Pathol 2014, 184:2560e2572) explored the regulatory
relationship between cytokines, MMP-3, and SDC4 in rat and
human nucleus pulposus cells. Tumor necrosis factor (TNF)-a
and IL-1b cytokine treatment increasedMMP-3 expression and
promoter activity. Loss-of-function studies conﬁrmed that NF-
kB, p38a/b2/g/d, and extracellular signal-regulated kinase
(ERK)2, but not ERK1, contributed to cytokine-dependent in-
duction of MMP3 promoter activity. Transforming growth
factor-b blocked TNF-aeinduced MMP-3 up-regulation and
Sdc4 expression, counteracting the NF-kB pathway. Control-
ling these pathways may slow the progression of IVDD and
matrix catabolism.
